QUEBEC CITY, April 23, 2013 /PRNewswire/ - Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX: AEZ) (the "Company") newly appointed President and
CEO, David A. Dodd will hold an introductory analyst and investor
conference call on Thursday, April 25, 2013 at 4:30 p.m., Eastern Time.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers:
in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.
A replay of the webcast will also be available on the Company's website
for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Help employers find you! Check out all the jobs and post your resume.